| Literature DB >> 29165341 |
Michele Guescini1, Serena Maggio2, Paola Ceccaroli3, Michela Battistelli4, Giosuè Annibalini5, Giovanni Piccoli6, Piero Sestili7, Vilberto Stocchi8.
Abstract
Myogenic differentiation is triggered, among other situations, in response to muscle damage for regenerative purposes. It has been shown that during myogenic differentiation, myotubes release extracellular vesicles (EVs) which participate in the signalling pattern of the microenvironment. Here we investigated whether EVs released by myotubes exposed or not to mild oxidative stress modulate the behaviour of targeted differentiating myoblasts and macrophages to promote myogenesis. We found that EVs released by oxidatively challenged myotubes (H₂O₂-EVs) are characterized by an increased loading of nucleic acids, mainly DNA. In addition, incubation of myoblasts with H₂O₂-EVs resulted in a significant decrease of myotube diameter, myogenin mRNA levels and myosin heavy chain expression along with an upregulation of proliferating cell nuclear antigen: these effects collectively lead to an increase of recipient myoblast proliferation. Notably, the EVs from untreated myotubes induced an opposite trend in myoblasts, that is, a slight pro-differentiation effect. Finally, H₂O₂-EVs were capable of eliciting an increased interleukin 6 mRNA expression in RAW264.7 macrophages. Notably, this is the first demonstration that myotubes communicate with surrounding macrophages via EV release. Collectively, the data reported herein suggest that myotubes, depending on their conditions, release EVs carrying differential signals which could contribute to finely and coherently orchestrate the muscle regeneration process.Entities:
Keywords: C2C12; H2O2; exosomes; extracellular vesicles; intercellular communication; myogenic differentiation; oxidative stress
Mesh:
Substances:
Year: 2017 PMID: 29165341 PMCID: PMC5713454 DOI: 10.3390/ijms18112488
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Exposure of myotubes to oxidative stress. C2C12 myotubes were treated with 0.3 mM H2O2 for 1 h and then extracellular vesicles (EVs) were collected after 18 h of recovery (blue arrow) (a); cell viability was evaluated after the collection of EVs using calcein AM, the results are represented as mean ± standard deviation (SD); n = 3 (b).
Figure 2Characterization of EVs released by myotubes following oxidative challenge. EVs released by oxidatively injured (H2O2-EVs) and intact (Ctrl-EVs) C2C12 myotubes were analysed and counted using a nanoparticle tracking assay, and results are represented as mean ± SEM; n = 4 (a); transmission electron microscopy analysis of EVs released by oxidatively injured myotubes, the arrows indicate the presence of small vesicles of about 30–100 nm in diameter (bar 200 nm) (b); Western blot analysis of myotube cell bodies, Ctrl-EVs and H2O2-EVs; blots were probed with antibodies against calnexin, CD63 and Tsg101 (c); total RNA (d) and DNA (e) contained in EVs were quantified using RiboGreen™ and PicoGreen™ (molecular probes), respectively; results are represented as mean ± SD; n = 3; * p < 0.05. The DNA carried by H2O2-EVs was analyzed using electrophoresis migration after DNase1 digestion with and without disruption of the membranous envelope by sonication (f).
Figure 3Treatments of myoblasts with EVs released by myotubes following oxidative challenge. Schematic representation of myoblast treatments with EVs (a); myoblasts were treated using 1 × 1010 particles/mL (indicated as Ctrl-EVs or H2O2-EVs) or using 5 × 1010 particles/mL (indicated as Ctrl-EVs × 5 or H2O2-EVs × 5). Immunofluorescence analysis was performed 4 days after EV treatments (b); the obtained differentiation index (c), and the myotube size (d), were reported (n = 3, see Materials and Methods section). Myosin heavy chain (MyHC), proliferating cell nuclear antigen (PCNA) and tubulin (Tub) protein expression (e) and myogenin (MyoG) mRNA expression (f) analyses were carried out 24 h after EV addition; the results are represented as mean ± SD; n = 3; * p < 0.05; ** p < 0.01; *** p < 0.001. Migration of C2C12 cells after wounding: confluent cultures of C2C12 myoblasts were wounded with a sterile blade (T = 0 h), deprived of serum and treated with Ctrl-EVs or H2O2-EVs for 18 h (T = 18 h), then recolonization was quantified by light microscopy (magnification 40×; Zeiss) and reported as percentage of the higher one; the results are represented as mean ± SD (n = 4); * p < 0.05; ** p < 0.01 (g).
Figure 4Treatments of RAW264.7 macrophages with EVs released by myotubes following oxidative challenge. The blue arrow indicates the addition of myotube-derived EVs to RAW264.7 cells. RAW264.7 macrophages were treated using 1 × 1010 particles/mL from control (Ctrl-EVs) or oxidatively injured (H2O2-EVs) myotubes (a); MTT cell viability assay (b) and mRNA expression (c) analyses were performed 24 h after EV treatments. The results are represented as mean ± SD; n = 4; * p < 0.05.